Top Psychiatry Researchers Honoured with International Career Development AwardMay 24, 2005American Psychiatric Association and AstraZeneca Reward '2004 Young Minds in Psychiatry' Winners The American Psychiatric Association (APA) and AstraZeneca today announced the winners of their prestigious 'Young Minds in Psychiatry' awards programme which aims to recognise excellence and support development amongst young leaders in the field of psychiatry research from around the world. The award presentations took place at the APA's 158th Annual Meeting during the Early Research Career Breakfast meeting, where it was also announced that submissions are now being welcomed for the 2005 awards programme. The 2004 Awards Programme attracted over 35 submissions from around the world and these were reviewed by a panel of acclaimed psychiatry experts. "The extremely high quality of these entrants is a very positive indicator for the future of mental health research around the world," commented Dr. Darrel A. Regier, Executive Director of the American Psychiatric Institute for Research and Education. "The diversity and insightfulness of the entries made the judging process a particularly difficult task." Submissions were reviewed based on the strength of proposal, the future potential of the candidates, and their career advancement prospects. Five winners were selected across two research categories; schizophrenia and bipolar disorder. A winner from both the US and the international community were selected in each category for the importance and value of their research proposal, each winning a career development award of $45,000. This year, due to the outstanding level of excellence amongst the entrants, two applicants share the International Bipolar Award. The 2004 Young Minds in Psychiatry Awards were won by Raymond Y. Cho, USA (schizophrenia), Stefan Leucht, Germany (schizophrenia), Alexander B. Niculescu III, USA (bipolar disorder), Jose M. Goikolea, Spain (bipolar disorder), and Etheldreda Nakimuli-Mpungu, Uganda (bipolar disorder). Dr. Nakimuli-Mpungu's award will enable her to review bipolar disorder amongst HIV / AIDS patients in Uganda, an important area where little research exists to date. HIV positive patients who also have bipolar disorder but are untreated, may not take their prescribed HIV medication which can cause resistance to the HIV drugs and lead to further complications. Dr. Nakimuli-Mpungu plans to develop a PhD proposal from this study. Dr. Leucht will review duration of response of antipsychotics in schizophrenia patients, a poorly understood area despite 50 years of effective antipsychotic drug development. Dr. Leuchts' long-term goal is to run his own research institute with a focus on evidence-based medicine in mental health. Dr. Niculescu's study has the goal of developing and applying a novel approach to better understand the phenotypic structure of psychotic disorders, called PhenoChipping. Commenting on winning the award, Dr. Niculescu noted that "winning the Young Minds in Psychiatry Award provides recognition, impetus and seed money for the more ambitious aspects of my work." His ultimate career goals as an academic psychiatrist and translational researcher are to help understand how the brain works, by integrating genetics with neurobiology, and at a clinical level, to help foster the era of personalized medicine in psychiatry. Dr. Cho will be investigating how impaired context processing impacts the life of those people living with schizophrenia, which could ultimately aid in the development of early prognostic indicators as well as help improve cognition in this debilitating disorder. Dr. Goikolea will be investigating the role that fronto-temporal white matter plays in patients with bipolar disorder, and this project will form the basis of his doctoral thesis. "This award will allow me to devote a large proportion of my work to creating a whole research line on neuroimaging in bipolar disorder," commented Dr. Goikolea. The 2005 'Young Minds in Psychiatry Awards Programme' is also launched today at the APA meeting. Researchers who are within 5 years of completing a psychiatric residency can apply for the award by submitting a proposal of scientific merit that demonstrates academic promise and explaining how winning an award will further their career. "We encourage applications across a broad range of activities, and are extremely proud to be a part of this award programme supporting rising stars in the field of psychiatry. It is important for us to nurture and support those at the front-line of future research and advance in this medical field" comments Jamie Mullen, AstraZeneca. Application forms can be found via: http://youngminds.astrazeneca.com/ Shire Health International |
|||||||||||||||||||||
| Related Schizophrenia Current Events and Schizophrenia News Articles Schizophrenia gene's role may be broader, more potent, than thought UCSF scientists studying nerve cells in fruit flies have uncovered a new function for a gene whose human equivalent may play a critical role in schizophrenia. Full recovery now possible for an 'untreatable' mental illness Patients coping with the chaos and misery of Borderline Personality Disorder now have reason for strong confidence in making major life changes through a new treatment, Schema Therapy. Immune system activated in schizophrenia Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system. Why can't chimps speak? If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not? Developmental delay could stem from nicotinic receptor deletion The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics. Fighting Sleep, Penn Researchers Reverse the Cognitive Impairment Caused By Sleep Deprivation A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation. Testicular tumors may explain why some diseases are more common in children of older fathers A rare form of testicular tumour has provided scientists with new insights into how genetic changes (mutations) arise in our children. CSHL-led team discovers rare mutation dramatically increasing schizophrenia risk An international team of researchers led by geneticist Jonathan Sebat, Ph.D., of Cold Spring Harbor Laboratory (CSHL), has identified a mutation on human chromosome 16 that substantially increases risk for schizophrenia. Faulty 'wiring' in the brain triggers onset of schizophrenia A new study by researchers at the Institute of Psychiatry (IoP), King's College London has discovered abnormalities in the white matter of the brain that seem to be critical for the timing of schizophrenia. General anesthetics lead to learning disabilities in animal models Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature. More Schizophrenia Current Events and Schizophrenia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||